Cardinal Health, Inc. operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cardinal Health with three other
drug stores in North America:
Walgreens Boots Alliance Inc
(2020
sales of $139.54 billion
of which 77%
was Retail Pharmacy USA),
AmerisourceBergen Corporation
($189.89 billion
of which 96%
was Pharmaceutical Distribution), and
McKesson Corporation
($231.05 billion
of which 79%
was U.S. Pharmaceutical and Specialty Soluti).
Sales Analysis.
Cardinal Health reported sales of $152.92 billion
for the
fiscal
year ending
June of 2020.
This
represents
an
increase of 5.1%
versus 2019, when the company's sales were $145.53 billion.
Sales at Cardinal Health have increased during each of the previous five years
(and since 2015, sales have increased a total of 49%).
Sales of Pharmaceutical saw an increase
of
5.8% in 2020, from
$129.92 billion to $137.50 billion.
Not all segments of Cardinal Health experienced an increase in sales in 2020:
sales of Medical fell 1.2% to $15.44 billion.